Cargando…
Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
Objective: Sevelamer hydrochloride is a phosphate binder used to treat hyperphosphatemia in chronic kidney disease (CKD) patients that can reduce valvular and vascular calcification. The aim of this study was to examine the effects of sevelamer treatment on calcification in bioprosthetic heart valve...
Autores principales: | Meng, Zhen, Li, Zhe, Zhang, Erli, Zhang, Li, Liu, Qingrong, Wu, Yongjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514018/ https://www.ncbi.nlm.nih.gov/pubmed/34660741 http://dx.doi.org/10.3389/fcvm.2021.740038 |
Ejemplares similares
-
Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease
por: Guo, Shuai, et al.
Publicado: (2022) -
Fibrin deposition on bovine pericardium tissue used for bioprosthetic heart valve drives its calcification
por: Poitier, Bastien, et al.
Publicado: (2023) -
Bioprosthetic valve monitoring in patients with carcinoid heart disease
por: Honan, Kevin A., et al.
Publicado: (2023) -
Bioprosthetic Heart Valves: Upgrading a 50-Year Old Technology
por: Li, Kan Yan Chloe
Publicado: (2019) -
Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves
por: Williams, David F., et al.
Publicado: (2021)